Cysteine Endopeptidases

Type: Keyphrase

Name: Cysteine Endopeptidases

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Poznan University of Medical Sciences

New Data from Poznan University of Medical Sciences Illumina. . .

New Data from Poznan University of Medical Sciences Illuminate Findings in Cysteine EndopeptidasesEnzymes and CoenzymesNewsRx.comBy a News Reporter-Staff News Editor at Drug Week -- Current study results on Enzymes and Coenzymes have been published. According ... [Published Equities.com - May 01 2013]

Entities: Poznan University of Medical Sciences, Enzymes, Illumina Inc, Cysteine Endopeptidases

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Enzymes and Coenzymes: Study Results from Focas Research Institute in the Area of Cysteine Endopeptidases Reported

Today's Medical & Research NewsEnzymes and Coenzymes2013 APR 25 -- By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish new report on Enzymes and Coenzymes. According to news reporting out of Dublin, Ireland, by NewsRx ... [Published NewsRX - Apr 25 2013]

Entities: Enzymes, Cysteine Endopeptidases, Cytotoxicity

First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Peking Union Medical College

Study Data from Peking Union Medical College Hospital Update Understanding of Drug Delivery Systems

By a News Reporter-Staff News Editor at Biotech Week A new study on Drugs and Therapies is now available. According to news reporting out of Beijing, People's Republic of China, by NewsRx editors, research stated, "There is an urgent need for novel therapeutic ... [Published Pharmacy Choice - Apr 17 2013]

Entities: Peking Union Medical College, Drug Delivery, folic acid, Liposome, doxorubicin

Quotes

...According to news reporting originating from Poznan, Poland, by NewsRx correspondents, research stated, "Cyclic pyrazoles exhibit cytotoxicity to human cancer cells through apoptosis induction. We investigated the proapoptotic activities of two novel synthetic pyrazoles: 5-(p-toluenesulfonyl)pyrazolo[4,3-f]quinoline (tospyrquin) and 5-chloro-3-(p-toluenesulfonyl)indazole (tosind) in HT29 colon cancer cells which are characterised by point mutation (G/A in codon 273) in the p53 gene, which causes the lack of functionality of the p53 protein."

New Data from Poznan University of Medical Sciences Illumina. . . [Published Equities.com - May 01 2013]

According to the news editors, the research concluded: "This contribution reports on the intracellular mechanism of PAMAM dendrimer cytotoxicity in human keratinocytes. In all cases, the magnitude and evolution of responses depend on dendrimer generation and dose. Experimental data were supported by numerical simulation using only two variables. It is suggested that responses can be quantified in terms of rate constants rather than effective concentrations."

Enzymes and Coenzymes: Study Results from Focas Research Institute in the Area of Cysteine Endope ... [Published NewsRX - Apr 25 2013]

"In a further aspect of the invention there is provided novel processes and novel intermediates useful in preparing the presently invented Akt/PKB inhibiting compounds."

Patent Issued for Inhibitors of Akt Activity [Published Equities.com - Apr 25 2013]